SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-025567
Filing Date
2011-03-15
Accepted
2011-03-15 16:23:31
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K g26459e10vk.htm 10-K 1004776
2 EX-10.12 g26459exv10w12.htm EX-10.12 19156
3 EX-10.25 g26459exv10w25.htm EX-10.25 4314
4 EX-23 g26459exv23.htm EX-23 8129
5 EX-31.1 g26459exv31w1.htm EX-31.1 9453
6 EX-31.2 g26459exv31w2.htm EX-31.2 9452
7 EX-32.1 g26459exv32w1.htm EX-32.1 4840
8 EX-32.2 g26459exv32w2.htm EX-32.2 4825
9 GRAPHIC g26459g2645903.gif GRAPHIC 9241
10 GRAPHIC g26459g2645901.gif GRAPHIC 3734
11 GRAPHIC g26459g2645902.gif GRAPHIC 205451
  Complete submission text file 0000950123-11-025567.txt   1367345
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 11688817
SIC: 2836 Biological Products, (No Diagnostic Substances)